FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

3,819 letters. Newest first.

  1. Zenzi Pharmaceutical Industries Pvt. Ltd.

    Zenzi Pharmaceutical Industries refused FDA requests for records about prescription drugs made for the U.S. market.

    High risk
  2. Marshalls Traditional Healthcare CC

    Marshalls Traditional Healthcare, an OTC drug maker in South Africa, lacked finished-product release testing and process validation.

    High risk
  3. ABR Laboratory LLC

    FDA warned ABR Laboratory, a contract drug testing lab, that unverified microbial test methods and missed investigations made tested drugs adulterated.

    High risk
  4. Tyche Industries Ltd

    FDA warned Tyche Industries over falsified records, dirty equipment, and untested raw materials at its API plant.

    High risk
  5. Jagsonpal Pharmaceuticals Limited

    Jagsonpal Pharmaceuticals cited for API CGMP and listing failures after Indian inspection, leading to US import alert.

    High risk
  6. AmWiner & Raphe Holdings, LLC dba rapheGenerics Corp

    FDA cited rapheGenerics for manufacturing-quality failures and unapproved minoxidil hair regrowth drugs.

    High risk
  7. Robbins Instruments, LLC

    Robbins Instruments marketed Dermo-Jet Needleless Injector without FDA clearance and had quality system violations.

    High risk
  8. Gorilla Vapes of East Brunswick

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  9. Chengdu Innovation Pharmaceutical Co., Ltd.

    FDA warned Chengdu Innovation Pharmaceutical over CGMP (manufacturing quality rules) failures in API (drug ingredient) manufacturing, including no identity testing of incoming materials.

    High risk
  10. Wuhu Nuowei Chemistry Co., Ltd.

    FDA cited Wuhu Nuowei Chemistry for API CGMP deviations in impurity testing, stability data, and cleaning, and placed products on import alert.

    High risk
  11. ISOThrive, Inc.

    ISOThrive ran two human studies of a supplement used as a drug without submitting a required IND.

    High risk
  12. Strukmyer LLC dba Strukmyer Medical

    Strukmyer Medical was cited for current good manufacturing practice violations after FDA found repeated microbial contamination in water used to make OTC drugs.

    High risk
  13. Shantou Kangjie Daily Chemical Industry Co., Ltd

    FDA warns Shantou Kangjie over CGMP failures for OTC drugs, including untested ethanol and no quality unit.

    High risk
  14. Imperial Palace Commodity -Dongguan- Co., Ltd.

    FDA warns Chinese maker of OTC alcohol wipes that weak component testing and process validation make its drugs adulterated.

    High risk
  15. Center for Instrumental Analysis of China Pharmaceutical University

    Center for Instrumental Analysis of China Pharmaceutical University cited for incomplete API testing records and no quality unit.

    High risk
  16. BioStem Life Sciences

    FDA says BioStem Life Sciences made unapproved umbilical cord and amniotic products with significant CGMP violations.

    High risk
  17. Global Calcium Pvt. Limited

    FDA cites Global Calcium API plant for falsified records, deleted files, facility leaks and incomplete impurity profiles; products on Import Alert 66-40.

    High risk
  18. Talla Imports, LLC

    FDA says Talla Imports lacked required foreign supplier safety plans for Swedish toffee, cookies and candy.

    Medium
  19. Fagron Compounding Services, LLC dba Fagron Sterile Service

    FDA warns Fagron Sterile Services about unsafe sterile drug production and labeling problems at its Wichita facility.

    High risk
  20. Kardesler Ucan Yaglar Sanayi Anonim Sirketi

    Turkey-based OTC drug maker Kardesler Ucan failed to test glycerin, propylene glycol and ethanol for dangerous impurities and is on US import alert.

    High risk
  21. Chara Biologics, Inc.

    FDA warns Chara Biologics over unapproved, unlicensed CharaExo, CharaCore, CharaOmni.

    High risk
  22. Mihon Corp. d/b/a VitalityVita and Boulla, LLC

    FDA warns Mihon Corp./Boulla that VitalityXtra, PeakMax, ZapMax and ZoomMax supplements contain hidden sildenafil and diclofenac and are unapproved, misbranded drugs.

    High risk
  23. Evolutionary Biologics Inc.

    FDA warned Evolutionary Biologics that its exosome and umbilical-cord products are unapproved new drugs and unlicensed biologics sold with disease-treatment claims.

    High risk
  24. Sanofi

    FDA warned Sanofi subsidiary Genzyme over manufacturing quality failures at its Framingham, MA API plant.

    High risk
  25. www.weightcrunchshop.com

    FDA warned www.weightcrunchshop.com about selling unapproved and misbranded semaglutide and oxycodone drugs to U.S. consumers online.

    High risk
  26. Atlanta Supersource, Inc.

    Atlanta Supersource made OTC hand sanitizers on equipment shared with toxic industrial chemicals and lacked testing, FDA says.

    High risk
  27. Nyumbani Hakuna Matata LLC

    FDA warns Buffalo seafood importer Nyumbani Hakuna Matata over missing safety checks for dried fish from Tanzania.

    High risk
  28. COFISA - Conservas de Peixe da Figueira, S.A.

    FDA found COFISA's canned sardine and tuna food-safety plans inadequate, with missing hazards and weak histamine (spoilage toxin) controls.

    High risk
  29. Premium Fresh Growers LLC

    FDA warns Premium Fresh Growers it lacked required foreign supplier checks for imported limes, cilantro, and carrots.

    Medium
  30. INCELL Corporation LLC

    FDA warned INCELL Corporation for making an unapproved amniotic-fluid drug without validating its sterile manufacturing process.

    High risk
  31. Duong Ha Processing Trading Seafood Company Limited

    FDA warns Vietnam seafood processor Duong Ha over HACCP failures for frozen scombrotoxin-forming fish.

    High risk
  32. Salt City Baking Company, LLC

    FDA says Salt City Baking's ready-to-eat bread was made under insanitary conditions, with insects, mold and missing food-safety controls.

    High risk
  33. Western Innovations, Inc.

    FDA warns Western Innovations over manufacturing-rule violations in Acetyl-glutathione supplements after Denver inspection.

    Medium
  34. Miyajima Shoyu Co., Ltd.

    Miyajima Shoyu lacked FDA-filed scheduled processes for acidified Wasabi Dressing, making it adulterated.

    High risk
  35. Midwest Goods Inc., d/b/a Midwest Distribution and Midwest Distribution Illinois

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  36. By George Food Specialties Inc.

    By George Food Specialties lacked required foreign supplier verification program for imported mayonnaise and hot sauce, FDA says.

    Medium
  37. Integra LifeSciences Corporation

    FDA warned Integra LifeSciences over bacterial toxin test and sterilization failures at three medical device plants.

    High risk
  38. Hologic, Inc.

    FDA warns Hologic over design-control and reporting failures for implantable BioZorb markers, including missed medical device reports and a correction report.

    High risk
  39. Xoran Technologies, LLC

    FDA warned Xoran Technologies that its computed tomography devices and software violate quality rules and lack required marketing clearance.

    High risk
  40. Phillips Precision, Inc.

    FDA says Phillips Precision, a contract maker of orthopedic implants and instruments, violated device quality rules for cleaning and process controls.

    High risk
  41. Randox Laboratories Limited

    FDA warned Randox Laboratories over inadequate risk analysis and corrective actions for carryover errors in RX series analyzers.

    High risk
  42. Reedhill Ventures LLC, d/b/a Vape On

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  43. Elite Brothers, LLC

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  44. Ecig Charleston LLC

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  45. Indoco Remedies Limited

    FDA warned Indoco Remedies over manufacturing quality failures at its Goa plant, including unreliable microbial testing and aseptic processing deficiencies.

    High risk
  46. XO Biologix, LLC

    XO Biologix markets MaviX, an amniotic-fluid product, as an unapproved new drug and unlicensed biologic.

    High risk
  47. Candymar Produce Inc

    Candymar Produce, a Texas importer, had no FSVP for imported carrots, squash and cabbage, FDA found.

    Medium
  48. Evolution Pets LLC

    Evolution Pets marketed SeizureGuard Plus and Life Span Arthritis & Mobility as unapproved drugs for treating dog diseases.

    High risk
  49. Nutrition Strength Ltd.

    FDA warns Nutrition Strength Ltd. over unapproved dog seizure and blood-support supplements marketed as animal drugs.

    High risk
  50. Energetic Essences, LLC dba Pet Essences

    FDA warned Pet Essences that its Seizures formula is an unapproved new animal drug marketed to treat seizures in animals.

    High risk